Original Scientific Article
Vascular endothelial growth factor (VEGF) in abdominal fluid in dogs with oncological and non-oncological diseases
Tsanko Hristov*

Mac Vet Rev 2019; 42 (2): 163 - 168

10.2478/macvetrev-2019-0021

Received: 15 April 2019

Received in revised form: 02 July 2019

Accepted: 03 August 2019

Available Online First: 31 August 2019

Published on: 15 October 2019

Correspondence: Tsanko Hristov, hristov_vet@abv.bg

Abstract

The vascular endothelial growth factor (VEGF) is a multifunctional cytokine stimulating the growth of vascular endothelial cells, survival and proliferation, inhibiting apoptosis. It is one of the most potent stimulants of vascular permeability. VEGF is found at high levels in inflammatory and tumour-associated pleural and abdominal effusions and is involved in their occurrence. In the present study, the blood plasma and abdominal fluid VEGF levels were assayed in thirty-one client-owned dogs with neoplastic and non-neoplastic diseases by means of enzyme-linked immunosorbent assay (ELISA). The VEGF concentration in abdominal fluid of dogs (n=6) with ascites was 190.70±34.35 pg/ml, in dogs (n=6) with peritonitis: 1449.81±365.42 pg/ml and in dogs (n=9) with tumour-associated effusion: 1993.13±202.56 pg/ml. Blood plasma VEGF of healthy dogs (control group, n=10) was 36.79±5.72 pg/ml, in dogs with ascites: 57.92±2.88 pg/ml, in dogs with peritonitis: 76.98±7.24 pg/ml and in dogs with tumour-associated effusion: 173.50±40.9 pg/ml. There were substantial differences between blood plasma and abdominal fluid VEGF levels.

Keywords: vascular endothelial growth factor, abdominal fluid, tumours, dogs


References

  1. Ferrara, N. (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 25(4): 581-611. https://doi.org/10.1210/er.2003-0027 PMid:15294883
  2. Pidgeon, G.P., Barr, M.P., Harmey, J.H., Foley, D.A., Bouchier-Hayes, D.J. (2001). Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer. 85(2): 273-278. https://doi.org/10.1054/bjoc.2001.1876 PMid:11461089 PMCid:PMC2364032
  3. Takano, Т., Ohyama, T., Kokumoto, A., Satoh, R., Hohdatsu, Ts. (2011). Vascular endothelial growth factor(VEGF), producedbyfelineinfectiousperitonitis (FIP) virus-infected monocytes and macrophages, induces vascular permeability and effusion in cats with FIP. Virus Research 158, 161-168.
    https://doi.org/10.1016/j.virusres.2011.03.027 PMid:21473893
  4. Zhao, X., Xian, S., Xiao-li, L. (2012). Expression and clinical significance of STAT3, P-STAT3, and VEGF-C in small cell lung cancer. Asian Pacific J Cancer Prev. 13, 2873-2877.
    https://doi.org/10.7314/APJCP.2012.13.6.2873 PMid:22938476
  5. Ghasemi, M., Omid, E., Farshad, N., Ahmadreza, B., Saeid, A., Laleh, V., Moghimpour, R. (2011). Immunohistochemical expression of vascular endothelial growth factor and its correlation with tumor grade in breast ductal carcinoma. Acta Medica Iranica 49(12): 776-779.
  6. Stefanou, D., Anna, B., Sevasti, K., Evdokia, A., Dionysios, J.P., Niki, J.A. (2004). Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. In Vivo 18(2): 155-160.
  7. Campos, A.G., Campos, J. A., Sanches, D. S., Dagli, M. L., Matera, J. M. (2012). Immunohistochemical evaluation of vascular endothelial growth factor (VEGF) in splenic hemangiomas and hemangiosarcomas in dogs. Open Journal of Veterinary Medicine 2, 191-195. https://doi.org/10.4236/ojvm.2012.24030
  8. Martano, M., Restucci, B., Ceccarelli, D. M., Muzio, L. L., Maiolino, P. (2016). Immunohistochemical expression of vascular endothelial growth factor in canine oral squamous cell carcinomas. Oncology Letters 11, 399-404. https://doi.org/10.3892/ol.2015.3847 PMid:26870224 PMCid:PMC4727185
  9. Millanta, F., Andreani, G., Rocchigiani, G., Lorenzi, D., Poli, A. (2016). Correlation between cyclo-oxygenase-2 and vascular endothelial growth factor expression in canine and feline squamous cell carcinomas. J Comp Pathol. 154(4): 297-303. https://doi.org/10.1016/j.jcpa.2016.02.005  PMid:27012907
  10. Barrientos, S., Olivera, S., Michael, S.G., Harold, B., Marjana, T. (2008). Growth factors and cytokines in wound healing. Wound Rep Reg. 16, 585-601.
    https://doi.org/10.1111/j.1524-475X.2008.00410.x PMid:19128254
  11. Robinson, R.S., Woad, K.J., Hammond, A.J., Laird, M., Hunter, M.G., Mann, G.E. (2009). Angiogenesis and vascular function in the ovary. Reproduction 138, 869-881.
    https://doi.org/10.1530/REP-09-0283 PMid:19786399
  12. Sack, U., Hoffmann, M., Zhao, X.J., Chan, K.S., Hui, D.S.C., Gosse, H., Engelmann, L., Schauer, J., Emmrich, F., Hoheisel, G. (2005). Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J. 25, 600-604. https://doi.org/10.1183/09031936.05.00037004  PMid:15802331
  13. Bekes, I., Thomas, W.P.F., Tanja, K., Volker, M., Wolfgang, J., Achim, W., Wulff, C. (2016). Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer? Molecular Cancer 15, 13.
    https://doi.org/10.1186/s12943-016-0497-3 PMid:26868378 PMCid:PMC4751711
  14. Sun, X., Dong, W., Gao, L., Jiang, X. (2003). Detection of VEGF levels in ascites and peritoneal fluid. Chinese Journal of Cancer Research 15(4): 310-314.
    https://doi.org/10.1007/BF02974898
  15. Askari, V.R., Vafa, B.R., Parvin, Z., Narges, F., Pouria, R., Amir, H.S., Rakhshandeh, H. (2018). Evaluation of the effects of Iranian propolis on the severity of post operational-induced peritoneal adhesion in rats. Biomedicine & Pharmacotherapy 99, 346-353. https://doi.org/10.1016/j.biopha.2018.01.068 PMid:29665643
  16. Clifford, C.A., Dez, H., Matthew, W.B., Carolyn, J.H., Kenneth, J.D., Karin, U.S. (2002). Vascular endothelial growth factor concentrations in body cavity effusions in dogs. J Vet Intern Med. 16, 164-168. https://doi.org/10.1111/j.1939-1676.2002.tb02349.x PMid:11899032
  17. Wergin, M.C., Kaser-Hotz, B. (2004). Plasma vascular endothelial growth factor (VEGF) measured in seventy dogs with spontaneously occurring tumours. In Vivo 18(1): 15-19.
  18. Kato, Y., Asano, K., Mogi, T., Kutara, K., Teshima, K., Edamura, K. Tsumagari, S., Hasegawa, A., Tanaka, S. (2007). Clinical significance of circulating vascular endothelial growth factor in dogs with mammary gland tumors. J Vet Med Sci. 69(1): 77-80. https://doi.org/10.1292/jvms.69.77 PMid:17283406
  19. Wolfesberger, B., de Arespacohaga, G., Willmann, A., Gerner, M., Miller, W., Schwendenwein, I., et al. (2007). Expression of vascular endothelial growth factor and its receptors in canine lymphoma. Journal of Comparative Pathology 137(1): 30-40. https://doi.org/10.1016/j.jcpa.2007.03.003 PMid:17467003
  20. Kraft, A., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, C., Marme, D., Gastl, G. (1999). Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (Phila). 85, 178-187. https://doi.org/10.1002/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7
  21. Rudlowski, C., Pickart, A.K., Fuhljahn, C., Friepoertner, T., Schlehe, B., Biesterfeld, S., Schroeder, W. (2006). Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up. Int J Gynecol Cancer. 16(1): 183-189. https://doi.org/10.1136/ijgc-00009577-200602001-00029 PMid:16515588
  22. Roskoski, J.R. (2007). Vascular endothelial growth factor (VEGF) signaling in tumor progression. Critical Reviews in Oncology/Hematology 62, 179-213. 
    https://doi.org/10.1016/j.critrevonc.2007.01.006 PMid:17324579
  23. Dvorak, H.F. (2002). Vascular permeability factor/ vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. Journal of Clinical Oncology 20(21): 4368- 4380. https://doi.org/10.1200/JCO.2002.10.088 PMid:12409337
  24. Queiroga, F.L., Pires, I., Parente, M., Gregório, H., Lopes, C.S. (2011). COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer. Vet J. 189(1): 77-82. https://doi.org/10.1016/j.tvjl.2010.06.022 PMid:20675158


Copyright

© 2019 Hristov T. This is an open-access article publishedunder the terms of the Creative Commons Attribution License whichpermits unrestricted use, distribution, and reproduction in any medium,provided the original author and source are credited.

Conflict of Interest Statement

The authors declared that they have no potential conflict of interest with respect to the authorship and/or publication of this article.

Citation Information

Macedonian Veterinary Review. Volume 42, Issue 2, Pages 163-168, e-ISSN 1857-7415, p-ISSN 1409-7621, DOI: 10.2478/macvetrev-2019-0021, 2019